Beiderman promised J&J positive trial results BEFORE the trials were done!!

Biederman is one of the slime-bag psychiatrists who Senator Grassley has busted for conflicts of interest with pharmaceutical companies while doing research at a university. In this case Harvard. Biederman is also almost single-handedly responsible for the massive drugging of so-called bipolar children. He has been the leading KEY NOTE LEADER (a pharma creation and title) dictating standard of care for our youngest and most vulnerable.

We can be profoundly grateful that this crap is coming to light, bit by bit, thanks to Senator Grassley. Background history on some of the awesome work Grassley is doing can be found here at Furious Seasons. The guy is doing some heavy duty clean up. Unfortunatley the filth is so deep it might be never-ending

Here is the latest dish from The Wall Street Journal Health Blog:

Court documents are coming to light that suggest Harvard psychiatrist Joseph Biederman told Johnson & Johnson, before certain trials of its drugs were started, that he expected positive results.

Biederman is one of a number of prominent doctors targeted by Sen. Chuck Grassley’s investigation into conflicts of interest among doctors. Late last year, he agreed to stop working on clinical trials sponsored by industry until completion of a probe of his alleged lack of disclosure of more than $1.6 million in payments he received from companies including J&J and Eli Lilly, both makers of prominent psychiatric drugs.

According to court documents, Biederman made a presentation to J&J execs in which he displayed a slide that referred to a proposed study of the company’s antipsychotic Risperdal, known generically as risperidone, in preschool children, the New York Times reports. The trial “will support the safety and effectiveness of risperidone in this age group,” as NYT quotes the slide.

Another slide discussed a trial that would compare Risperdal with competitors in managing pediatric bipolar disorder. The trial “will clarify the competitive advantages of risperidone vs. other neuroleptics,” as NYT quotes it the documents.

Biederman’s attorneys are trying to get a judge to seal his testimony and accompanying documents in a multistate suit in which he is a key witness, saying they “could be immensely damaging to him, both personally and professionally,” the Boston Globe reports. The suit involves more than 2,000 patients, including children, who say they have been injured by drugs known as atypical antipsychotics. Growing use of psychiatric drugs in children has been a center of controversy in the past couple of years. (continue reading here)

Update: Others following this story: Furious Seasons, Soulful Sepulcher, Seroxat Sufferers, The Carlat Psychiatry Blog.

Leave a Reply

Powered by

Up ↑

%d bloggers like this: